Hydroxychloroquine and Azithromycin

DRUG3 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Latin American Cooperative Oncology Group, Yaounde Central Hospital

Conditions

COVID-19Covid-19Sars-CoV2

Phase 2

HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19

WithdrawnNCT04575558

Latin American Cooperative Oncology GroupSars-CoV2

Start: 2020-06-30End: 2020-10-30Updated: 2020-10-05

Phase 3

Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients

WithdrawnNCT04371406

Assistance Publique - Hôpitaux de ParisCovid-19

Start: 2020-04-30End: 2020-09-30Updated: 2020-10-27

Phase 4

Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19

Yaounde Central HospitalCOVID-19

Start: 2020-10-05End: 2021-09-05Target: 200Updated: 2021-01-20

Related Papers

Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE - COALITION VIII randomised clinical trial.

2023-05-1812 citations